The protective role of IL-37 in tumors has been demonstrated in a number of cancers, e.g. in human hepatocellular carcinoma (52), perhaps via inhibiting M2 macrophages (10), in lung cancer (53) via inhibiting angiogenesis, and in an animal model (54). This evidence concerns the gene IL37 and hepatocellular carcinoma.